Valuation bioMérieux

Equities

Market Closed - Euronext Paris Other stock markets 16:55:00 21/04/2026 BST			After hours 17:38:12
90.60 ^EUR	+0.50%		90.62	+0.03%

04-20	BioMérieux S.A.Announces Multi-Country Health Economic Analysis Assessing Impact of Deploying Fast Identification and Antimicrobial Susceptibility Testing Early in Care Pathway for Patients with Bloodstream Infections At High-Risk of Sepsis	CI
04-13	RBC Capital Favors Diasorin Over bioMérieux

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	14,780	11,591	11,883	12,214	13,023	10,634	-	-
Change	-	-21.58%	2.52%	2.78%	6.63%	-18.35%	-	-
Enterprise Value (EV) ¹	14,439	11,544	12,049	12,255	12,915	10,120	9,745	9,418
Change	-	-20.05%	4.38%	1.7%	5.39%	-21.64%	-3.7%	-3.35%
P/E ratio	24.7x	25.6x	33.4x	28.4x	33x	19.6x	17.4x	15.3x
PBR	4.75x	-	3.19x	2.92x	3.2x	2.28x	2.07x	1.9x
PEG	-	-1x	-1.6x	1.4x	-4x	0.5x	1.4x	1.1x
Capitalization / Revenue	4.38x	3.23x	3.23x	3.07x	3.2x	2.5x	2.34x	2.18x
EV / Revenue	4.28x	3.22x	3.28x	3.08x	3.17x	2.38x	2.14x	1.94x
EV / EBITDA	14x	13.4x	14.6x	13.4x	13.5x	9.4x	8.19x	7.22x
EV / EBIT	18.4x	19.7x	27.4x	19.9x	23x	13.7x	11.8x	10.2x
EV / FCF	27.7x	59.1x	105x	37.2x	27.9x	21.6x	18.6x	16.9x
FCF Yield	3.61%	1.69%	0.96%	2.69%	3.58%	4.63%	5.37%	5.9%
Dividend per Share ²	0.85	0.85	0.85	0.9	0.98	1.129	1.218	1.403
Rate of return	0.68%	0.87%	0.84%	0.87%	0.89%	1.25%	1.35%	1.56%
EPS ²	5.06	3.82	3.01	3.64	3.34	4.598	5.18	5.876
Distribution rate	16.8%	22.3%	28.2%	24.7%	29.3%	24.6%	23.5%	23.9%
Net sales ¹	3,376	3,589	3,675	3,980	4,070	4,245	4,547	4,867
EBITDA ¹	1,032	864.2	827	913.9	959.7	1,077	1,189	1,304
EBIT ¹	784.3	587.2	439	614.7	561.1	739.1	827.5	919.8
Net income ¹	601.1	452.4	358	432	397.5	545.7	611.4	695.3
Net Debt ¹	-341	-47	166	40.9	-108	-513.8	-888.3	-1,215
Reference price ²	124.90	97.92	100.60	103.50	110.30	90.15	90.15	90.15
Nbr of stocks (in thousands)	118,336	118,374	118,124	118,006	118,067	117,954	-	-
Announcement Date	02/03/22	07/03/23	14/03/24	07/03/25	27/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOMÉRIEUX	19.61x	2.38x	9.4x	1.25%	12.53B
GUARDANT HEALTH, INC.	-30.91x	9.74x	-69.34x	-.--%	11.95B
CARIS LIFE SCIENCES, INC.	211.6x	5.45x	32.66x	-.--%	6B
LANTHEUS HOLDINGS, INC.	23.44x	3.65x	10.44x	-	5.46B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	21.18x	7.26x	16.68x	2.64%	5.22B
DIASORIN S.P.A.	18.67x	3.25x	10.12x	2.06%	3.94B
10X GENOMICS, INC.	-25.76x	4.38x	-30.33x	-.--%	3.14B
AUTOBIO DIAGNOSTICS CO., LTD.	17.09x	-	-	3.47%	2.85B
Average	31.86x	5.16x	-2.91x	1.35%	6.39B
Weighted average by Cap.	27.92x	5.46x	-8.83x	1.04%